About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Scottish National Blood Transfusion Service
›
top-articles
Scottish National Blood Transfusion Service
26
(top 1%)
papers
985
(top 1%)
citations
16
(top 1%)
h
-index
24
(top 1%)
g
-index
27
all documents
1.0K
doc citations
436
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells
Blood
2007
283
2
Application of a Time-Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its Components
Vox Sanguinis
1999
117
3
Intermittent Exposure of Primitive Quiescent Chronic Myeloid Leukemia Cells to Granulocyte-Colony Stimulating Factor
In vitro
Promotes their Elimination by Imatinib Mesylate
Clinical Cancer Research
2006
86
4
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
Eurosurveillance
2020
64
5
Fibrin sealant reduces suture line bleeding during carotid endarterectomy: A randomised trial
European Journal of Vascular and Endovascular Surgery
1995
55
6
Expansion of Foxp3
+
T‐cell populations by
Candida albicans
enhances both Th17‐cell responses and fungal dissemination after intravenous challenge
European Journal of Immunology
2014
55
7
In vivo
platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib
British Journal of Haematology
2001
45
8
Prion protein and developments in its detection
Transfusion Medicine
2001
42
9
Application of a Time–Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its Components
Vox Sanguinis
1999
38
10
Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen
Blood
2012
33
11
Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver
Scientific Reports
2017
29
12
THE IMPACT OF NEW-VARIANT CREUTZFELDT-JAKOB DISEASE ON BLOOD TRANSFUSION PRACTICE
British Journal of Haematology
1999
25
13
Hepatitis B virus genotypes and precore mutations in Scottish blood donors
Vox Sanguinis
2005
25
14
Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
Frontiers in Immunology
2020
25
15
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
JCI Insight
2022
24
16
Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus
Vox Sanguinis
2001
17
17
Seroprevalence of lyme borreliosis in Scottish blood donors
Transfusion Medicine
2015
17
18
Species differences in the blood content of the normal cellular isoform of prion protein, PrPc , measured by time-resolved fluoroimmunoassay
Vox Sanguinis
2001
16
19
Detection of HTLV-I and -II in Scottish blood donor samples and archive donations
Vox Sanguinis
2006
16
20
Automatically Controlled Continuous Recovery of Plasma Protein Fractions for Clinical Use: A Preliminary Report
Vox Sanguinis
1970
10
21
A report: “Reagents for the 1990’s”
Immunohematology
1991
8
22
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
Gut
2022
3
23
First HIV ‘window period’ donation in a UK blood donor
Transfusion Medicine
2005
2
24
Human immunodeficiency virus 1 subtypes detected in Scottish blood donors
Vox Sanguinis
2009
2
25
BLOOD FRACTIONS
Lancet, The
1954
0
26
Does the Storage Time of Transfused Red Blood Cells Influence Critically Ill Patients?: The authors reply
Critical Care Medicine
2004
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.